trending Market Intelligence /marketintelligence/en/news-insights/trending/ArdrUpAyPGZioTXj88RdiA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Aerie Pharmaceuticals closes stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Aerie Pharmaceuticals closes stock offering

Aerie Pharmaceuticals Inc. closed an underwritten public offering of 1,395,349 common shares at $53.75 apiece for net proceeds of about $72.4 million.

The company also sold 906,858 common shares via an at-the-market program for another $50 million.

Cantor Fitzgerald & Co. acted as the sole book runner for both transactions.